Table 1 Prognostic genomic features by hypermutation status

From: Prognostic genome and transcriptome signatures in colorectal cancers

Feature

nHM

HM

Longer survival

Shorter survival

Longer survival

Shorter survival

Coding driver gene mutation

APCOS,RFS

SIN3AOS

ARHGAP5OS,RFS

ARID2OS

BRAF OS,RFS

RNF43OS,RFS

ARHGAP5RFS

RNF43RFS

TGFBR2RFS

BCL9OS

PCBP1RFS

TRPS1OS

Mitochondrial gene mutation

MT-CYBOS,RFS

Non-coding driver gene mutation

ID2OS

HS3ST1OS

DAPK1RFS

CNV

+8p11.1OS

+20q11.1OS,RFS

+20q11.21OS

+20q13.12OS

+20q13.33OS

−4q34.1OS

−8p23.1OS

−11p15.5RFS

−12q24.33RFS

−16p13.3RFS

−17p12RFS

−17p13.3RFS

−17q12OS

−17q21.2OS

−17q21.31OS

−17q25.3OS,RFS

−21p12OS

−3p21.31RFS

−4q22.1RFS

−11p15.5OS,RFS

−15q26.3RFS

+19q11OS

SV

SMAD4RFS

TCF7L2OS,RFS

Mutational signature

SBS44OS

  1. Prognostic features identified by multivariable Cox with adjustment for tumour site, pretreatment status, tumour stage, age group and tumour grade. OS, overall survival for stages I–IV. RFS, recurrence-free survival for stages I–III.